Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience
Clinical Breast Cancer · 2025
DOI: 10.1016/j.clbc.2024.10.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Nusrat Jahan und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL; Department of Oncology, Mayo Clinic, Rochester, MN. Electro…. Hauptthemen laut MEDLINE: Breast Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, Practice Patterns, Physicians'. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIMHD NIH HHS, Mayo Clinic.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL; Department of Oncology, Mayo Clinic, Rochester, MN. Electronic address: njahan@uabmc.edu.
- Department of Oncology, Mayo Clinic, Rochester, MN.
- Department of Quantitative Health Services, Mayo Clinic, Rochester, MN.
- Department of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ.
- Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Förderung
- NCI NIH HHS
- NIMHD NIH HHS
- Mayo Clinic
Zitieren
APA
Jahan, N., Taraba, J., Boddicker, N. J., Giridhar, K. V., Leon-Ferre, R. A., Tevaarwerk, A. J., Cathcart-Rake, E., O'Sullivan, C. C., Peethambaram, P. P., Hobday, T. J., Mina, L. A., Batalini, F., Advani, P., Sideras, K., Haddad, T. C., Ruddy, K. J., Goetz, M. P., Couch, F. J., & Yadav, S. (2025). Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2024.10.006
Vancouver
Jahan N, Taraba J, Boddicker NJ, Giridhar KV, Leon-Ferre RA, Tevaarwerk AJ, et al. Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2024.10.006
BibTeX
@article{Jahan2025,
author = {Jahan, Nusrat and Taraba, Jodi and Boddicker, Nicholas J and Giridhar, Karthik V and Leon-Ferre, Roberto A and Tevaarwerk, Amye J and Cathcart-Rake, Elizabeth and O'Sullivan, Ciara C and Peethambaram, Prema P and Hobday, Timothy J and Mina, Lida A and Batalini, Felipe and Advani, Pooja and Sideras, Kostandinos and Haddad, Tufia C and Ruddy, Kathryn J and Goetz, Matthew P and Couch, Fergus J and Yadav, Siddhartha},
title = {Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience},
journal = {Clinical Breast Cancer},
year = {2025},
doi = {10.1016/j.clbc.2024.10.006}
}
EUVIMED